Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$178.49 - $250.39 $535,648 - $751,420
-3,001 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$148.38 - $186.78 $625,124 - $786,904
-4,213 Reduced 58.4%
3,001 $531,000
Q4 2019

Feb 11, 2020

SELL
$140.81 - $159.49 $73,784 - $83,572
-524 Reduced 6.77%
7,214 $1.14 Million
Q3 2019

Nov 12, 2019

BUY
$145.61 - $159.87 $4,659 - $5,115
32 Added 0.42%
7,738 $1.15 Million
Q2 2019

Aug 14, 2019

SELL
$122.29 - $148.82 $595,307 - $724,455
-4,868 Reduced 38.71%
7,706 $0
Q1 2019

May 15, 2019

BUY
$102.78 - $138.28 $12,333 - $16,593
120 Added 0.96%
12,574 $0
Q4 2018

Feb 15, 2019

SELL
$98.38 - $125.32 $30,301 - $38,598
-308 Reduced 2.41%
12,454 $1.34 Million
Q3 2018

Nov 14, 2018

SELL
$97.19 - $124.54 $33,530 - $42,966
-345 Reduced 2.63%
12,762 $0
Q2 2018

Aug 08, 2018

BUY
$83.88 - $102.21 $1.1 Million - $1.34 Million
13,107 New
13,107 $0
Q1 2018

May 16, 2018

SELL
$82.06 - $95.19 $295,662 - $342,969
-3,603 Closed
0 $0
Q4 2017

Feb 15, 2018

SELL
$84.49 - $90.09 $71,985 - $76,756
-852 Reduced 19.12%
3,603 $0
Q3 2017

Nov 14, 2017

BUY
$81.79 - $96.62 $364,374 - $430,442
4,455
4,455 $0

Others Institutions Holding MASI

About MASIMO CORP


  • Ticker MASI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 52,530,200
  • Market Cap $8.98B
  • Description
  • Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximet...
More about MASI
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.